Robert Darwin > Sidley Austin LLP > London, England > Lawyer Profile
Sidley Austin LLP Offices

70 St Mary Axe
London
EC3A 8BE
England
- Firm Profile
- Go to...
Robert Darwin

Work Department
Private Equity
Position
Partner
Career
ROBERT DARWIN has a broad international practice focused on private equity and M&A. He executes the most strategic and critical private transactions for global corporates, funds, and other private investors. Robert advises clients across a wide range of industries including industrials, technology, consumer goods, and leisure.
Robert is particularly known for his work with global life sciences and healthcare corporations and investors and has led deals of all types in these industries, including strategic collaborations, acquisitions, private equity buyouts, licensing, and investment deals.
Lawyer Rankings
London > Industry focus > Life sciences and healthcare
(Leading partners)Known for its ability to handle regulatory issues relating to orphan drugs, cell and gene therapy products, and digital health tools, Sidley Austin LLP is additionally active across areas including product liability, cybersecurity, M&A, and collaborations and licencing. Maria Isabel Manley leads the life sciences team for Sidley’s office in London and frequently brings her knowledge of EU and UK regulatory and competition law to bear when representing clients before regulatory authorities. Robert Darwin is a key contact for global life sciences and healthcare corporations looking to do transactions. James Wood is well-placed to handle M&A work in the sector. Solicitor advocate Chris Boyle, and Zina Chatzidimitriadou, who excels in market access strategy matters, are further recommended.
Lawyer Rankings
- Leading partners London > Industry focus > Life sciences and healthcare
- Life sciences and healthcare London > Industry focus
Top Tier Firm Rankings
Firm Rankings
- Finance > Debt capital markets
- Finance > Derivatives and structured products
- Industry focus > Life sciences and healthcare
- Finance > Securitisation
- Finance > Acquisition finance
- Finance > Corporate restructuring & insolvency
- TMT (technology, media and telecoms) > Fintech: regulatory
- Projects, energy and natural resources > Infrastructure: M&A and acquisition financing
- Insurance > Insurance: corporate and regulatory
- Corporate and commercial > Private equity: transactions – high-value deals (£500m+)
- Dispute resolution > Banking litigation: investment and retail
- Real estate > Commercial property: investment
- Corporate and commercial > Corporate tax
- Risk advisory > Data protection, privacy and cybersecurity
- Corporate and commercial > Financial services: contentious
- Corporate and commercial > Financial services: non-contentious/regulatory
- Crime, fraud and licensing > Fraud: white-collar crime (advice to individuals)
- Risk advisory > Regulatory investigations and corporate crime (advice to corporates)
- Dispute resolution > Commercial litigation: premium
- Investment fund formation and management > Private funds
- Corporate and commercial > EU and competition
- Corporate and commercial > M&A: Upper Mid-Market And Premium Deals, £750m+
- Real estate > Property finance